These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 20512116)

  • 41. Quantitative analysis of methylation status of the PAX1 gene for detection of cervical cancer.
    Huang TH; Lai HC; Liu HW; Lin CJ; Wang KH; Ding DC; Chu TY
    Int J Gynecol Cancer; 2010 May; 20(4):513-9. PubMed ID: 20442585
    [TBL] [Abstract][Full Text] [Related]  

  • 42. HPV16 E6*II gene expression in intraepithelial cervical lesions as an indicator of neoplastic grade: a pilot study.
    Pastuszak-Lewandoska D; Bartosińska-Dyc A; Migdalska-Sęk M; Czarnecka KH; Nawrot E; Domańska D; Szyłło K; Brzeziańska E
    Med Oncol; 2014 Mar; 31(3):842. PubMed ID: 24436016
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Increased risk of cervical disease among human immunodeficiency virus-infected women with severe immunosuppression and high human papillomavirus load(1).
    Heard I; Tassie JM; Schmitz V; Mandelbrot L; Kazatchkine MD; Orth G
    Obstet Gynecol; 2000 Sep; 96(3):403-9. PubMed ID: 10960634
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Low- and high-risk CIN 1 and 2 lesions: prospective predictive value of grade, HPV, and Ki-67 immuno-quantitative variables.
    Kruse AJ; Baak JP; Janssen EA; Bol MG; Kjellevold KH; Fianne B; Lovslett K; Bergh J
    J Pathol; 2003 Apr; 199(4):462-70. PubMed ID: 12635137
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Regression of low-grade cervical intraepithelial neoplasia in patients with HLA-DRB1*13 genotype.
    Sastre-Garau X; Cartier I; Jourdan-Da Silva N; De Crémoux P; Lepage V; Charron D
    Obstet Gynecol; 2004 Oct; 104(4):751-5. PubMed ID: 15458897
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Identification of HPV genotypes causing cervical precancer using tissue-based genotyping.
    Venetianer R; Clarke MA; van der Marel J; Tota J; Schiffman M; Dunn ST; Walker J; Zuna R; Quint W; Wentzensen N
    Int J Cancer; 2020 May; 146(10):2836-2844. PubMed ID: 32037535
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Evaluation of CIN2+ /CIN3+ risk of different HPV subtypes infection combined with abnormal cytology status].
    Luo HX; Du H; Liu ZH; Zhang LJ; Wang C; Wu RF
    Zhonghua Zhong Liu Za Zhi; 2018 Mar; 40(3):232-238. PubMed ID: 29575846
    [No Abstract]   [Full Text] [Related]  

  • 48. MicroRNA expressions in HPV-induced cervical dysplasia and cancer.
    Gocze K; Gombos K; Kovacs K; Juhasz K; Gocze P; Kiss I
    Anticancer Res; 2015 Jan; 35(1):523-30. PubMed ID: 25550598
    [TBL] [Abstract][Full Text] [Related]  

  • 49. CyclinA1 Promoter Methylation in Self-Sampling Test.
    Oranratanaphan S; Kengsakul M; Triratanachat S; Kitkumthorn N; Mutirangura A; Termrungruanglert W
    Asian Pac J Cancer Prev; 2020 Oct; 21(10):2913-2917. PubMed ID: 33112548
    [TBL] [Abstract][Full Text] [Related]  

  • 50. CCR2-V64I polymorphism is associated with increased risk of cervical cancer but not with HPV infection or pre-cancerous lesions in African women.
    Chatterjee K; Dandara C; Hoffman M; Williamson AL
    BMC Cancer; 2010 Jun; 10():278. PubMed ID: 20537184
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Regression of cervical intraepithelial neoplasia and loss of human papillomavirus (HPV) infection is associated with cell-mediated immune responses to an HPV type 16 E7 peptide.
    Kadish AS; Timmins P; Wang Y; Ho GY; Burk RD; Ketz J; He W; Romney SL; Johnson A; Angeletti R; Abadi M;
    Cancer Epidemiol Biomarkers Prev; 2002 May; 11(5):483-8. PubMed ID: 12010863
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Changes in genotype prevalence of human papillomavirus over 10-year follow-up of a cervical cancer screening cohort].
    Dong L; Hu SY; Zhang Q; Feng RM; Zhang L; Zhao XL; Ma JF; Shi SD; Zhang X; Pan QJ; Zhang WH; Qiao YL; Zhao FH
    Zhonghua Liu Xing Bing Xue Za Zhi; 2017 Jan; 38(1):20-25. PubMed ID: 28100371
    [No Abstract]   [Full Text] [Related]  

  • 53. Type-specific HPV geno-typing improves detection of recurrent high-grade cervical neoplasia after conisation.
    Heymans J; Benoy IH; Poppe W; Depuydt CE
    Int J Cancer; 2011 Aug; 129(4):903-9. PubMed ID: 21064091
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Toll-like receptors: Important immune checkpoints in the regression of cervical intra-epithelial neoplasia 2.
    Halec G; Scott ME; Farhat S; Darragh TM; Moscicki AB
    Int J Cancer; 2018 Dec; 143(11):2884-2891. PubMed ID: 30121951
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Performance of the Roche AMPLICOR human papillomavirus (HPV) test in prediction of cervical intraepithelial neoplasia (CIN) in women with abnormal PAP smear.
    Monsonego J; Bohbot JM; Pollini G; Krawec C; Vincent C; Merignargues I; Haroun F; Sednaoui P; Monfort L; Dachez R; Syrjänen K
    Gynecol Oncol; 2005 Oct; 99(1):160-8. PubMed ID: 16023184
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Three-year longitudinal data on the clinical performance of the Abbott RealTime High Risk HPV test in a cervical cancer screening setting.
    Poljak M; Oštrbenk A; Seme K; Šterbenc A; Jančar N; Vrtačnik Bokal E
    J Clin Virol; 2016 Mar; 76 Suppl 1():S29-S39. PubMed ID: 26643051
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Prediction of recurrence after treatment for high-grade cervical intraepithelial neoplasia: the role of human papillomavirus testing and age at conisation.
    Verguts J; Bronselaer B; Donders G; Arbyn M; Van Eldere J; Drijkoningen M; Poppe W
    BJOG; 2006 Nov; 113(11):1303-7. PubMed ID: 16978225
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Clinical Regression of High-Grade Cervical Intraepithelial Neoplasia Is Associated With Absence of
    Kremer WW; Dick S; Heideman DAM; Steenbergen RDM; Bleeker MCG; Verhoeve HR; van Baal WM; van Trommel N; Kenter GG; Meijer CJLM; Berkhof J
    J Clin Oncol; 2022 Sep; 40(26):3037-3046. PubMed ID: 35512257
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Prediction value with a novel and accurate tissue-based human papillomavirus detection method in low-grade squamous intraepithelial lesions.
    Wang H; He Z; Han X; Zhang D; Zhang S
    Cancer Med; 2022 Jul; 11(13):2576-2587. PubMed ID: 35343653
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Grading the severity of cervical neoplasia based on combined histopathology, cytopathology, and HPV genotype distribution among 1,700 women referred to colposcopy in Oklahoma.
    Wentzensen N; Schiffman M; Dunn ST; Zuna RE; Walker J; Allen RA; Zhang R; Sherman ME; Wacholder S; Jeronimo J; Gold MA; Wang SS
    Int J Cancer; 2009 Feb; 124(4):964-9. PubMed ID: 19030188
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.